We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZTA icon
951
Azenta
AZTA
$1.49B
$35.3M 0.01%
3,085,404
+86,600
+3% +$992K
KFRC icon
952
Kforce
KFRC
$1.08B
$35.3M 0.01%
1,544,726
-380,940
-20% -$8.46M
HZNP
953
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$35.3M 0.01%
1,016,389
+154,389
+18% +$4.71M
AVD icon
954
American Vanguard Corp
AVD
$62.8M
$35.3M 0.01%
2,557,476
-6,300
-0.2% -$82.5K
TUES
955
DELISTED
Tuesday Morning Corp
TUES
$35.2M 0.01%
3,126,890
+1,058,950
+51% +$15.4M
PPL
956
PPL Corp
PPL
$26.8B
$35.1M 0.01%
1,190,562
-69,307
-6% -$2.17M
WM icon
957
Waste Management
WM
$89.6B
$34.8M 0.01%
751,011
+6,890
+0.9% +$346K
HOPE icon
958
Hope Bancorp
HOPE
$1.85B
$34.7M 0.01%
2,348,310
-20,360
-0.9% -$298K
HTGC icon
959
Hercules Capital
HTGC
$3.17B
$34.6M 0.01%
2,996,380
+121,940
+4% +$1.58M
WASH icon
960
Washington Trust Bancorp
WASH
$767M
$34.6M 0.01%
876,338
-160,604
-15% -$6.11M
TROW icon
961
T. Rowe Price
TROW
$23.7B
$34.6M 0.01%
444,794
+21,400
+5% +$1.73M
BJRI icon
962
BJ's Restaurants
BJRI
$1.42B
$34.6M 0.01%
713,573
-5,310
-0.7% -$256K
DPZ icon
963
Domino's
DPZ
$11.6B
$34.6M 0.01%
304,828
+21,050
+7% +$2.27M
HBM icon
964
Hudbay
HBM
$11.8B
$34.3M 0.01%
+4,111,830
New +$37.8M
SFE
965
DELISTED
Safeguard Scientifics, Inc.
SFE
$34.2M 0.01%
1,756,843
-7,600
-0.4% -$139K
SPWH icon
966
Sportsman's Warehouse
SPWH
$46.8M
$34.1M 0.01%
2,999,810
-27,500
-0.9% -$275K
TCF
967
DELISTED
TCF Financial Corporation
TCF
$34.1M 0.01%
2,050,098
-4,822
-0.2% -$77.5K
PII icon
968
Polaris
PII
$3.91B
$33.7M 0.01%
227,450
-20,011
-8% -$2.88M
HWKN icon
969
Hawkins
HWKN
$2.67B
$33.6M 0.01%
1,665,442
+2,640
+0.2% +$53.7K
EIG icon
970
Employers Holdings
EIG
$871M
$33.5M 0.01%
1,471,520
-29,330
-2% -$718K
DWA
971
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
$33.2M 0.01%
1,258,160
-52,790
-4% -$1.39M
ENTG icon
972
Entegris
ENTG
$25B
$33M 0.01%
2,263,522
-164,830
-7% -$2.31M
CSTM icon
973
Constellium
CSTM
$3.95B
$32.9M 0.01%
2,782,271
-1,777,030
-39% -$27.9M
NORD
974
DELISTED
Nord Anglia Education, Inc.
NORD
$32.9M 0.01%
+1,341,824
New +$33.6M
MIG
975
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
$32.9M 0.01%
3,820,419
-290,964
-7% -$2.48M

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.